Literature DB >> 11487006

The vascular biology of the glycoprotein Ib-IX-V complex.

M C Berndt1, Y Shen, S M Dopheide, E E Gardiner, R K Andrews.   

Abstract

It has long been recognized that binding of von Willebrand factor (vWf) by the platelet membrane glycoprotein (GP) Ib-IX-V complex initiates the cascade of events leading to thrombosis and haemostasis. In the last several years, however, it has become apparent that the GP Ib-IX-V complex plays a much broader role in vascular biology, a recognition in part due to the identification of novel adhesive ligands for GP Ib-IX-V such as P-selectin and Mac-1. Binding of vWf by the GP Ib-IX-V complex is also important in formation of the developing thrombus. Platelets can utilize the GP Ib-IX-V complex and PSGL-1 to roll on activated endothelium via surface-expressed endothelial P-selectin. The GP Ib-IX-V complex can bind the I domain of Mac-1, a binding interaction potentially relevant to transmigration of macrophages through mural thrombus, a process required for vessel remodeling post angioplasty. This review will focus on recent advances in our understanding of the structure and function of this important platelet receptor, with particular emphasis on insights made within the last two years.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487006

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  55 in total

Review 1.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Storage of buffy-coat-derived platelets in additive solution: in vitro effects on platelets of the air bubbles and foam included in the final unit.

Authors:  Per Sandgren; Kharija Saeed
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

3.  The dimerization interface of the glycoprotein Ibβ transmembrane domain corresponds to polar residues within a leucine zipper motif.

Authors:  Peng Wei; Xin Liu; Miao-Hui Hu; Li-Min Zuo; Ming Kai; Rui Wang; Shi-Zhong Luo
Journal:  Protein Sci       Date:  2011-09-12       Impact factor: 6.725

4.  Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.

Authors:  Maneesh Arya; Anatoly B Kolomeisky; Gabriel M Romo; Miguel A Cruz; José A López; Bahman Anvari
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

5.  Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet.

Authors:  Shi-Zhong Luo; Xi Mo; Vahid Afshar-Kharghan; Sankaranarayanan Srinivasan; José A López; Renhao Li
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

Review 6.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

7.  Specific heteromeric association of four transmembrane peptides derived from platelet glycoprotein Ib-IX complex.

Authors:  Shi-Zhong Luo; Renhao Li
Journal:  J Mol Biol       Date:  2008-07-22       Impact factor: 5.469

8.  Identification of a unique filamin A binding region within the cytoplasmic domain of glycoprotein Ibalpha.

Authors:  Susan L Cranmer; Inna Pikovski; Pierre Mangin; Philip E Thompson; Teresa Domagala; Mark Frazzetto; Hatem H Salem; Shaun P Jackson
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

9.  Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release.

Authors:  Haruhiko Tokuda; Gen Kuroyanagi; Takashi Onuma; Yukiko Enomoto; Tomoaki Doi; Hiroki Iida; Takanobu Otsuka; Shinji Ogura; Toru Iwama; Kumi Kojima; Osamu Kozawa
Journal:  Biomed Rep       Date:  2018-02-06

10.  Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.

Authors:  W O Tobin; J A Kinsella; G F Kavanagh; J S O'Donnell; R A McGrath; D R Collins; T Coughlan; D O'Neill; B Egan; S Tierney; T M Feeley; R P Murphy; Dominick J H McCabe
Journal:  J Neurol       Date:  2012-10-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.